Lv6
2600 积分 2024-01-27 加入
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
9天前
已完结
Five-Year Mortality Outcomes for Eating As Treatment (EAT), a Health Behavior Change Intervention to Improve Nutrition in Patients With Head and Neck Cancer: A Stepped-Wedge, Randomized Controlled Trial
19天前
已完结
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1
26天前
已完结
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial
1个月前
已完结
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial*
2个月前
已完结
Real‐life intraclass switch among IL‐17 inhibitors in psoriasis: results from a single‐centre, 24‐week, retrospective study
2个月前
已完结
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
2个月前
已完结
Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
2个月前
已完结
Non-factor Therapies for Hemophilia: Achievements and Perspectives
2个月前
已完结
New therapies in hemophilia: extend the half-life, mimic, or rebalance?
2个月前
已完结
皖公网安备34019202002308
